Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sizzling market heats up biotech buyout fever
Fierce Biotech
Wednesday, December 9, 2009 - 10:54am
tags:
biotech, M&A, Merrimack Pharmaceuticals, Hermes, Celgene, Glouchester Pharma
Sangamo drug looks promising in small strength trial
Fierce Biotech
Wednesday, December 9, 2009 - 10:36am
tags:
Sangamo BioSciences, ALS, drug trials
Gloucester Pharma Proves Single-Drug Model Can Work
WSJ Online
Wednesday, December 9, 2009 - 10:25am
tags:
Glouchester Pharma, Celgene, M&A, Istodax, non-Hodgkin's lymphoma
AstraZeneca's New Depression Drug Is a Cancelled Blood Pressure Medicine
BNET Pharma
Wednesday, December 9, 2009 - 10:23am
tags:
AstraZeneca, antidepressants, Targacept
Bristol-Myers $125 Million Plavix Accord Is Approved
Bloomberg
Wednesday, December 9, 2009 - 10:18am
tags:
Bristol-Myers Squibb, Plavix, settlements, Apotex, patents
FDA May Strengthen Antipsychotic Labels For Kids
Pharmalot
Wednesday, December 9, 2009 - 10:17am
tags:
antipsychotics, FDA, Eli Lilly, Zyprexa, AstraZeneca, Seroquel
The Top 10 Pharma Layoffs of 2009
Fierce Pharma
Wednesday, December 9, 2009 - 10:12am
tags:
layoffs, pharma industry
BioCryst Shorts Start to Cover
TheStreet.com
Wednesday, December 9, 2009 - 10:12am
tags:
Biocryst
Isis reacquires rights to drug, will revamp cancer program
San Diego Union Tribune, CA
Wednesday, December 9, 2009 - 10:10am
tags:
Isis Pharmaceuticals, Eli Lilly, cancer
Physicians More Likely To Report Drug Safety Information Through Electronic Health Records System
Yahoo
Wednesday, December 9, 2009 - 10:01am
tags:
electronic medical records, physicians, drug safety
Pfizer Tidbits: Dividend Murmurs, Generic Biotech, China R&D
WSJ Online
Wednesday, December 9, 2009 - 9:59am
tags:
Pfizer, generics, China, R&D
Novartis seeks to broaden use of some cancer drugs
Marketwatch
Wednesday, December 9, 2009 - 9:57am
tags:
cancer, Novartis, Tasigna, Zometa
Pfizer Seeks Boost From Copying Biotechnology Drugs
Bloomberg
Wednesday, December 9, 2009 - 9:12am
tags:
Pfizer, Amgen, Sanofi, biogenerics
Analyst: Pharma profit will fall on patent losses
Yahoo/AP
Tuesday, December 8, 2009 - 7:43pm
tags:
GSK, AstraZeneca, Bristol-Myers Squibb
Mylan, Wyeth ink Effexor agreements
Fierce Pharma
Tuesday, December 8, 2009 - 7:29pm
tags:
Wyeth, Mylan, Effexor, partnerships, venlafaxine, Pfizer
Roche’s Tamiflu Not Proven to Cut Flu Complications
Bloomberg
Tuesday, December 8, 2009 - 7:27pm
tags:
Flu, Tamiflu, Roche
Geron's developing cancer treatment meets midstage study goals
Yahoo/AP
Tuesday, December 8, 2009 - 7:26pm
tags:
Geron, drug study
Early and Often: A Drug Investor's Dream (Celgene)
Motley Fool
Tuesday, December 8, 2009 - 7:23pm
tags:
Revlimid, Celgene
Pharma’s Next Big Thing: Personalized Medicine
Minyanville
Tuesday, December 8, 2009 - 7:20pm
tags:
personalized medicine
Interim Data Lifts Geron, Stem Cell Rivals Mixed
Yahoo/Indie Research
Tuesday, December 8, 2009 - 11:23am
tags:
stem cells, Geron, Cytori, Aastrom

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.